Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Balance beginning (in shares) at Dec. 31, 2023		145,706,531
Balance beginning at Dec. 31, 2023	$ 422,507	$ 15	$ 382,854	$ 45,570	$ (5,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		585,760
Common stock issued upon exercise of stock options	83		83
Vested common stock awards (in shares)		212,633
Stock-based compensation	2,781		2,781
Net loss	(13,913)			(13,913)
Other comprehensive income (loss)	(3,274)				(3,274)
Ending balance (in shares) at Mar. 31, 2024		146,504,924
Ending balance at Mar. 31, 2024	408,184	$ 15	385,718	31,657	(9,206)
Balance beginning (in shares) at Dec. 31, 2024		148,574,227
Balance beginning at Dec. 31, 2024	338,365	$ 15	393,186	(38,127)	(16,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		2,116
Vested common stock awards (in shares)		930,333
Stock-based compensation	2,289		2,289
Net loss	(26,441)			(26,441)
Other comprehensive income (loss)	395				395
Ending balance (in shares) at Mar. 31, 2025		149,506,676
Ending balance at Mar. 31, 2025	$ 314,608	$ 15	$ 395,475	$ (64,568)	$ (16,314)